{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:12:09Z","timestamp":1793963529834,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["VEEPED"],"award-info":[{"award-number":["VEEPED"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR200411"],"award-info":[{"award-number":["NIHR200411"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR200411"],"award-info":[{"award-number":["NIHR200411"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/S01750X\/1"],"award-info":[{"award-number":["BB\/S01750X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/S01750X\/1"],"award-info":[{"award-number":["BB\/S01750X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S022244\/1"],"award-info":[{"award-number":["EP\/S022244\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S022244\/1"],"award-info":[{"award-number":["EP\/S022244\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S022244\/1"],"award-info":[{"award-number":["EP\/S022244\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused considerable morbidity and mortality worldwide. The protection provided by vaccines and booster doses offered a method of mitigating severe clinical outcomes and mortality. However, by the end of 2021, the global distribution of vaccines was highly heterogeneous, with some countries gaining over 90% coverage in adults, whereas others reached less than 2%. In this study, we used an age-structured model of SARS-CoV-2 dynamics, matched to national data from 152 countries in 2021, to investigate the global impact of different potential vaccine sharing protocols that attempted to address this inequity. We quantified the effects of implemented vaccine rollout strategies on the spread of SARS-CoV-2, the subsequent global burden of disease and the emergence of novel variants. We found that greater vaccine sharing would have lowered the total global burden of disease, and any associated increases in infections in previously vaccine-rich countries could have been mitigated by reduced relaxation of non-pharmaceutical interventions. Our results reinforce the health message, pertinent to future pandemics, that vaccine distribution proportional to wealth, rather than to need, may be detrimental to all.<\/jats:p>","DOI":"10.1038\/s41591-022-02064-y","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T12:06:35Z","timestamp":1666872395000},"page":"2416-2423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-5342","authenticated-orcid":false,"given":"Sam","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2992-2004","authenticated-orcid":false,"given":"Edward M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-4858","authenticated-orcid":false,"given":"Louise","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-7232","authenticated-orcid":false,"given":"Michael J.","family":"Tildesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"2064_CR1","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19\u201414 September 2021. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---14-september-2021 (2021)."},{"key":"2064_CR2","doi-asserted-by":"crossref","unstructured":"Vardavas, C. I. et al. Effectiveness of non-pharmaceutical measures (NPIs) on COVID-19 in Europe: a systematic literature review. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.11.11.21266216v1 (2021).","DOI":"10.1101\/2021.11.11.21266216"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2468-2667(20)30090-6","volume":"5","author":"BJ Cowling","year":"2020","unstructured":"Cowling, B. J. et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health 5, e279\u2013e288 (2020).","journal-title":"Lancet Public Health"},{"key":"2064_CR4","doi-asserted-by":"crossref","unstructured":"Demirg\u00fc\u00e7-Kunt, A., Lokshin, M. & Torre, I. The sooner, the better: the early economic impact of non-pharmaceutical interventions during the COVID-19 pandemic. World Bank Policy Research Working Paper (9257). https:\/\/openknowledge.worldbank.org\/handle\/10986\/33820 (2020).","DOI":"10.1596\/1813-9450-9257"},{"key":"2064_CR5","unstructured":"Ritchie, H. et al. Coronavirus Pandemic (COVID-19). Our World in Data. https:\/\/ourworldindata.org\/coronavirus"},{"key":"2064_CR6","unstructured":"World Health Organization. WHO Coronavirus COVID-19 Dashboard. https:\/\/covid19.who.int\/"},{"key":"2064_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/1468-0009.12503","volume":"99","author":"M Eccleston\u2010Turner","year":"2021","unstructured":"Eccleston\u2010Turner, M. & Upton, H. International collaboration to ensure equitable access to vaccines for COVID\u201019: the ACT\u2010Accelerator and the COVAX facility. Milbank Q. 99, 426\u2013449 (2021).","journal-title":"Milbank Q."},{"key":"2064_CR8","unstructured":"The Global Fund. The impact of COVID-19 on HIV, TB and malaria services and systems for health: a snapshot from 502 health facilities across Africa and Asia. https:\/\/www.theglobalfund.org\/en\/updates\/2021\/2021-04-13-the-impact-of-covid-19-on-hiv-tb-and-malaria-services-and-systems-for-health\/ (2021)."},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/cid\/ciaa933","volume":"72","author":"J Toor","year":"2021","unstructured":"Toor, J. et al. Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation. Clin. Infect. Dis. 72, 1463\u20131466 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"eabe0997","DOI":"10.1126\/sciadv.abe0997","volume":"7","author":"D Egger","year":"2021","unstructured":"Egger, D. et al. Falling living standards during the COVID-19 crisis: quantitative evidence from nine developing countries. Sci. Adv. 7, eabe0997 (2021).","journal-title":"Sci. Adv."},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1473-3099(21)00143-2","volume":"21","author":"S Moore","year":"2021","unstructured":"Moore, S., Hill, E. M., Tildesley, M. J., Dyson, L. & Keeling, M. J. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect. Dis. 21, 793\u2013802 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2064_CR12","doi-asserted-by":"publisher","first-page":"2101030","DOI":"10.2807\/1560-7917.ES.2021.26.48.2101030","volume":"26","author":"N Nicolay","year":"2021","unstructured":"Nicolay, N. et al. Initial assessment of the COVID-19 vaccination\u2019s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU\/EEA countries, December 2020 to May 2021. Euro. Surveill. 26, 2101030 (2021).","journal-title":"Euro. Surveill."},{"key":"2064_CR13","doi-asserted-by":"crossref","unstructured":"Marziano, V. et al. The effect of COVID-19 vaccination in Italy and perspectives for \u2018living with the virus\u2019. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.19.21253893v3 (2021).","DOI":"10.1101\/2021.03.19.21253893"},{"key":"2064_CR14","unstructured":"UK Health Security Agency. COVID-19 vaccine weekly surveillance reports. https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccine-weekly-surveillance-reports"},{"key":"2064_CR15","doi-asserted-by":"crossref","unstructured":"Andrews, N. et al. Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.09.15.21263583v2 (2021).","DOI":"10.1101\/2021.09.15.21263583"},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41591-021-01548-7","volume":"27","author":"KB Pouwels","year":"2021","unstructured":"Pouwels, K. B. et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat. Med. 27, 2127\u20132135 (2021).","journal-title":"Nat. Med."},{"key":"2064_CR17","doi-asserted-by":"crossref","unstructured":"Mahase, E. COVID-19 booster vaccines: what we know and who\u2019s doing what. BMJ 374, n2082 (2021).","DOI":"10.1136\/bmj.n2082"},{"key":"2064_CR18","unstructured":"Institute for Health Metrics and Evaluation (IHME). COVID-19 mortality, infection, testing, hospital resource use, and social distancing projections. https:\/\/www.healthdata.org\/covid\/"},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.abj0113","volume":"373","author":"MU Kraemer","year":"2021","unstructured":"Kraemer, M. U. et al. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science 373, 889\u2013895 (2021).","journal-title":"Science"},{"key":"2064_CR20","unstructured":"GISAID. Tracking of hCoV-19 Variants. https:\/\/gisaid.org\/hcov19-variants\/"},{"key":"2064_CR21","doi-asserted-by":"crossref","unstructured":"Wagner, C. E. et al. Vaccine nationalism and the dynamics and control of SARS-CoV-2. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.06.02.21258229v1 (2021).","DOI":"10.1101\/2021.06.02.21258229"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1473-3099(21)00202-4","volume":"21","author":"RN Thompson","year":"2021","unstructured":"Thompson, R. N., Hill, E. M. & Gog, J. R. SARS-CoV-2 incidence and vaccine escape. Lancet Infect. Dis. 21, 913\u2013914 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"2064_CR23","unstructured":"Hart, R. African nations should receive monkeypox vaccines first to avoid COVID inequality, agencies warn. https:\/\/www.forbes.com\/sites\/roberthart\/2022\/06\/16\/african-nations-should-receive-monkeypox-vaccines-first-to-avoid-covid-inequality-agencies-warn\/?sh=4ac999f7553f (2022)."},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/d41586-021-02532-4","volume":"597","author":"E Dolgin","year":"2021","unstructured":"Dolgin, E. et al. COVID vaccine immunity is waning\u2014how much does that matter? Nature 597, 606\u2013607 (2021).","journal-title":"Nature"},{"key":"2064_CR25","doi-asserted-by":"crossref","unstructured":"Watson, O. J. et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 22, 1293\u20131302 (2022).","DOI":"10.1016\/S1473-3099(22)00320-6"},{"key":"2064_CR26","doi-asserted-by":"crossref","unstructured":"de Albuquerque Veloso Machado, M., Roberts, B., Wong, B. L. H. & van Kessel, R. The relationship between the COVID-19 pandemic and vaccine hesitancy: a scoping review. Front. Public Health 9, 747787 (2021).","DOI":"10.3389\/fpubh.2021.747787"},{"key":"2064_CR27","doi-asserted-by":"crossref","unstructured":"Abecassis, A. Five priorities for universal COVID-19 vaccination. Lancet 398, 285\u2013286 (2021).","DOI":"10.1016\/S0140-6736(21)01371-4"},{"key":"2064_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/soej.12488","volume":"87","author":"P Boettke","year":"2021","unstructured":"Boettke, P. & Powell, B. The political economy of the COVID-19 pandemic. South. Econ. J. 87, 1090\u20131106 (2021).","journal-title":"South. Econ. J."},{"key":"2064_CR29","unstructured":"McGill University Vaccine Tracker Team. COVID-19 Vaccine Tracking Dashboard. https:\/\/covid19.trackvaccines.org\/vaccines\/approved\/"},{"key":"2064_CR30","doi-asserted-by":"crossref","first-page":"e00056521","DOI":"10.1590\/0102-311x00056521","volume":"37","author":"LEPF de Souza","year":"2021","unstructured":"de Souza, L. E. P. F. & Buss, P. M. Global challenges for equitable access to COVID-19 vaccination. Cad. Saude. Publica 37, e00056521 (2021).","journal-title":"Cad. Saude. Publica"},{"key":"2064_CR31","doi-asserted-by":"publisher","first-page":"e0260821","DOI":"10.1371\/journal.pone.0260821","volume":"16","author":"MB Hossain","year":"2021","unstructured":"Hossain, M. B. et al. COVID-19 vaccine hesitancy among the adult population in Bangladesh: a nationwide cross-sectional survey. PLoS ONE 16, e0260821 (2021).","journal-title":"PLoS ONE"},{"key":"2064_CR32","doi-asserted-by":"crossref","unstructured":"Srivastav, U. et al. Vaccine hesitancy for coronavirus SARS-CoV-2 in North India. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.10.24.21265455v1.full.pdf (2021).","DOI":"10.1101\/2021.10.24.21265455"},{"key":"2064_CR33","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1038\/s41467-021-25915-7","volume":"12","author":"L Dyson","year":"2021","unstructured":"Dyson, L. et al. Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics. Nat. Commun. 12, 5730 (2021).","journal-title":"Nat. Commun."},{"key":"2064_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/22221751.2021.2017757","volume":"11","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg. Microbes Infect. 11, 1\u20135 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"2064_CR35","unstructured":"Doria-Rose, N. A. et al. Booster of mRNA-1273 vaccine reduces SARS-CoV-2 Omicron escape from neutralizing antibodies. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.12.15.21267805v1 (2021)."},{"key":"2064_CR36","unstructured":"Willett, B. J. et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2022.01.03.21268111v2 (2022)."},{"key":"2064_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-02321-z","volume":"11","author":"V Rotshild","year":"2021","unstructured":"Rotshild, V., Hirsh-Raccah, B., Miskin, I., Muszkat, M. & Matok, I. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci. Rep. 11, 1\u20139 (2021).","journal-title":"Sci. Rep."},{"key":"2064_CR38","doi-asserted-by":"crossref","unstructured":"Eaton, L. COVID-19: WHO warns against \u2018vaccine nationalism\u2019 or face further virus mutations BMJ 372, n292 (2021).","DOI":"10.1136\/bmj.n292"},{"key":"2064_CR39","unstructured":"Bollyky, T. J. & Bown, C. P. The tragedy of vaccine nationalism: only cooperation can end the pandemic. Foreign Affairs https:\/\/www.foreignaffairs.com\/articles\/united-states\/2020-07-27\/vaccine-nationalism-pandemic (2020)."},{"key":"2064_CR40","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMp2103614","volume":"384","author":"IT Katz","year":"2021","unstructured":"Katz, I. T., Weintraub, R., Bekker, L.-G. & Brandt, A. M. From vaccine nationalism to vaccine equity\u2014finding a path forward. N. Engl. J. Med. 384, 1281\u20131283 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2064_CR41","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.abe2803","volume":"369","author":"EJ Emanuel","year":"2020","unstructured":"Emanuel, E. J. et al. An ethical framework for global vaccine allocation. Science 369, 1309\u20131312 (2020).","journal-title":"Science"},{"key":"2064_CR42","doi-asserted-by":"crossref","unstructured":"Basak, P. et al. Global perspective of COVID-19 vaccine nationalism. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.12.31.21268580v1 (2022).","DOI":"10.1101\/2021.12.31.21268580"},{"key":"2064_CR43","unstructured":"World Bank Group. World Development Indicators 2017. https:\/\/openknowledge.worldbank.org\/handle\/10986\/26447 (2017)."},{"key":"2064_CR44","doi-asserted-by":"publisher","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","volume":"13","author":"K Prem","year":"2017","unstructured":"Prem, K., Cook, A. R. & Jit, M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput. Biol. 13, e1005697 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"2064_CR45","unstructured":"Global Population Demographics (World Health Organization, 2021); https:\/\/apps.who.int\/gho\/data\/node"},{"key":"2064_CR46","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","volume":"5","author":"T Hale","year":"2021","unstructured":"Hale, T. et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat. Hum. Behav. 5, 529\u2013538 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"2064_CR47","unstructured":"Google. Google COVID-19 Community Mobility Reports. https:\/\/www.google.com\/covid19\/mobility\/"},{"key":"2064_CR48","doi-asserted-by":"publisher","first-page":"e69336","DOI":"10.7554\/eLife.69336","volume":"10","author":"A Karlinsky","year":"2021","unstructured":"Karlinsky, A. & Kobak, D. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. eLife 10, e69336 (2021).","journal-title":"eLife"},{"key":"2064_CR49","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199\u20131207 (2020)."},{"key":"2064_CR50","doi-asserted-by":"crossref","unstructured":"Abbott, S. et al. Estimating the increase in reproduction number associated with the Delta variant using local area dynamics in England. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.11.30.21267056v1.full (2021).","DOI":"10.1101\/2021.11.30.21267056"},{"key":"2064_CR51","doi-asserted-by":"crossref","unstructured":"Dagpunar, J. S. Interim estimates of increased transmissibility, growth rate, and reproduction number of the COVID-19 B.1.617.2 variant of concern in the United Kingdom. Preprint at https:\/\/www.medrxiv.org\/content\/10.1101\/2021.06.03.21258293v1 (2021).","DOI":"10.1101\/2021.06.03.21258293"},{"key":"2064_CR52","first-page":"1049\u20131051","volume":"3","author":"S Khare","year":"2021","unstructured":"Khare, S. et al. GISAID\u2019s role in pandemic response. China CDC Wkly. 3, 1049\u20131051 (2021).","journal-title":"China CDC Wkly."},{"key":"2064_CR53","doi-asserted-by":"publisher","first-page":"e1008849","DOI":"10.1371\/journal.pcbi.1008849","volume":"17","author":"S Moore","year":"2021","unstructured":"Moore, S., Hill, E. M., Dyson, L., Tildesley, M. J. & Keeling, M. J. Modelling optimal vaccination strategy for SARS-CoV-2 in the UK. PLoS Comput. Biol. 17, e1008849 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"2064_CR54","unstructured":"World Health Organization. Evidence assessment: Sinopharm\/BBIBP COVID-19 vaccine. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2021\/april\/2_sage29apr2021_critical-evidence_sinopharm.pdf (2021)."},{"key":"2064_CR55","doi-asserted-by":"crossref","unstructured":"Mahase, E. COVID-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ 372, n296 (2021).","DOI":"10.1136\/bmj.n296"}],"updated-by":[{"DOI":"10.1038\/s41591-023-02303-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02064-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02064-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T02:08:37Z","timestamp":1679969317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02064-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-02064-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"20 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-023-02303-w","URL":"https:\/\/doi.org\/10.1038\/s41591-023-02303-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}